Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Platinum-based Chemotherapy Response of Advanced Non-small Cell Lung Cancers in a Chinese Population-Reference-Cited by-同舟云学术

Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Platinum-based Chemotherapy Response of Advanced Non-small Cell Lung Cancers in a Chinese Population

Published:2012-05-30 Issue:5 Volume:13 Page:2157-2162
ISSN:1513-7368
Container-title:Asian Pacific Journal of Cancer Prevention
language:en
Short-container-title:Asian Pacific Journal of Cancer Prevention

Author:

Xu Jia-Li,Wang Zhen-Wu,Hu Ling-Min,Yin Zhi-Qiang,Huang Ming-De,Hu Zhi-Bin,Shen Hong-Bing,Shu Yong-Qian

Publisher

Asian Pacific Organization for Cancer Prevention

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Link

http://ocean.kisti.re.kr/downfile/crosscheck/apocp/JAKO201226935182963.pdf

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Variations of AKT1 are Associated with Risk Screening for Non-Alcoholic Fatty Liver Disease;Risk Management and Healthcare Policy;2023-07

2. Impact of AKT1 polymorphism on DNA damage, BTG2 expression, and risk of colorectal cancer development;Radiology and Oncology;2022-08-14

3. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?;International Journal of Molecular Sciences;2021-09-10

4. Effect of BRAF‑mediated PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells;Oncology Letters;2021-06-03

5. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions;European Journal of Pharmacology;2021-05